NCT03648411View on ClinicalTrials.gov

Drug Resistance Among Asymptomatic Infection

CompletedOBSERVATIONAL
Enrollment

765

Participants

Timeline

Start Date

January 12, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

May 20, 2020

Conditions
Drug Resistant MalariaAsymptomatic InfectionsMigrant Workers
Interventions
GENETIC

Drug resistance molecular markers

Proportion of the drug resistance molecular markers will be found-out and compared.

Trial Locations (1)

11191

Dr. Myat Phone Kyaw, Yangon

All Listed Sponsors
collaborator

National Malaria Control Program, Myanmar

OTHER_GOV

lead

Department of Medical Research, Lower Myanmar

OTHER

NCT03648411 - Drug Resistance Among Asymptomatic Infection | Biotech Hunter | Biotech Hunter